Differential Diagnosis of Influenza
Clinical Presentation and Diagnostic Approach
- The American Thoracic Society recommends assessing illness severity immediately, including vital signs, oxygen saturation, and mental status, to guide appropriate testing and treatment 1, 3
- The British Thoracic Society suggests using the CURB-65 score to assess pneumonia severity, which includes confusion, urea, respiratory rate, blood pressure, and age 8
- The American College of Chest Physicians recommends initiating antivirals within 48 hours for high-risk patients with suspected influenza, regardless of test results if testing is delayed 1, 6
- The use of C-reactive protein (CRP) is recommended to help diagnose pneumonia, with a CRP ≥30 mg/L plus suggestive symptoms increasing pneumonia likelihood 5, 6
- The American Academy of Pediatrics recommends against using aspirin in children <16 years due to the risk of Reye's syndrome 2, 3
Treatment Approach
- The American College of Chest Physicians strongly recommends against antibiotics when there is no clinical or radiographic evidence of pneumonia, normal vital signs, and lung examination, and bacterial co-infection is unlikely 1, 5, 6
- The Infectious Diseases Society of America recommends using empiric antibiotics when pneumonia is suspected but imaging cannot be obtained, radiographic evidence of pneumonia is present, or clinical deterioration or bacterial superinfection is suspected 1, 5
- The American Thoracic Society recommends symptomatic management for all patients, including paracetamol or ibuprofen for fever, myalgias, and headache, as well as rest and adequate fluid intake 2, 3
Severity Assessment and Escalation of Care
- The British Thoracic Society recommends using the CURB-65 score to determine the need for hospitalization, with a score of 0-1 indicating consideration for home treatment, a score of 2 indicating a short inpatient stay, and a score of ≥3 indicating management as severe pneumonia 8
- The American College of Chest Physicians recommends re-consulting or escalating care if patients show no improvement or worsening 48 hours after starting antivirals, develop dyspnea or chest pain, or have persistent high fever beyond 3-4 days 2, 3, 4